CLINUVEL withdraws SCENESSE® label expansion for adolescent erythropoietic protoporphyria 2024 Announcements . Clinical . News 03.06.2024
CLINUVEL and Valentech enter SCENESSE® LATAM partnership 2024 Announcements . Financial . News . Regulatory 23.05.2024
Notice of ceasing to be a substantial holder 2024 Announcements . Financial . News . Regulatory 26.04.2024